Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  NASDAQ OMX COPENHAGEN  >  Genmab A/S    GMAB   DK0010272202

GENMAB A/S

(GMAB)
  Report
Real-time Estimate Quote. Real-time Estimate CHI-X - 12/03 08:47:13 am
2356.5 DKK   -0.11%
12/01GENMAB A/S : Investor Presentation - December 2020
PU
11/25NOVARTIS : Genmab Announces Enapotamab Vedotin Update
AQ
11/24GENMAB A/S : Announces Enapotamab Vedotin Update
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Upcoming events on GENMAB A/S
12/05/20 | 03:45pm American Society of Hematology Meeting - Updated Phase 1 Results of Teclistamab, a B-cell Maturation
12/05/20 | 05:00pm American Society of Hematology Meeting - A Phase 1, First-in-Human Study of Talquetamab,
12/06/20 | 03:00pm AMERICAN SOCIETY OF HEMATOLOGY MEETING - APOLLO: Phase 3 Randomized Study of Subcutaneous Daratumuma
12/06/20 | 03:30pm American Society of Hematology Meeting - Subcutaneous Epcoritamab Induces Complete Responses With an
Past events on GENMAB A/S
11/17/20 | 09:40am Jefferies Healthcare Conference
11/13/20 | 08:30am Capital Markets Day
11/11/20 Society of Immunotherapy of Cancer Meeting - DuoBody-CD3x5T4
11/11/20 Society of Immunotherapy of Cancer Meeting - Tisotumab vedotin
Upcoming sector events for GENMAB A/S
12/03/20 IONIS PHARMACEUTICALS, INC. : Piper Sandler Health Care Conference
12/03/20 | 10:45am ASCENDIS PHARMA A/S : Evercore ISI HealthCONx Virtual Conference
12/03/20 | 11:20am KODIAK SCIENCES INC. : Evercore ISI HealthCONx Conference
12/03/20 | 02:15pm NOVAVAX, INC. : Evercore ISI HealthCONx Conference
More events
Past sector events for GENMAB A/S
12/02/20 | 01:00pm ULTRAGENYX PHARMACEUTICAL INC. : Evercore ISI HealthCONx Conference
12/02/20 | 11:20am GILEAD SCIENCES, INC. : Evercore ISI HealthCONx Conference
12/02/20 | 08:00am REGENERON PHARMACEUTICALS, INC. : Piper Sandler Health Care Conference
12/02/20 NOVAVAX, INC. : Investor Meeting
Annual publications
Annual results201520162017201820192020 (e)
Sales
M DKK
Released
Forecast
Spread
1 133
1 111
2,0%
1 816
1 804
0,69%
2 365
2 325
1,7%
3 025
2 905
4,1%
5 366
5 159
4,0%

9 831
Operating income
(EBITDA)
M DKK
Released
Forecast
Spread
762
659
16%
1 094
976
12%
1 414
1 315
7,6%
1 468
1 431
2,6%
2 777
2 460
13%

6 075
Operating profit
(EBIT)
M DKK
Released
Forecast
Spread
730
640
14%
1 053
1 016
3,7%
1 344
1 250
7,5%
1 380
1 388
-0,54%
2 638
2 372
11%

5 947
Pre-Tax Profit
(EBT)
M DKK
Released
Forecast
Spread
758
551
37%
1 130
1 022
11%
1 064
1 211
-12%
1 612
1 512
6,6%
2 859
2 705
5,7%

5 959
Net income
M DKK
Released
Forecast
Spread
764
682
12%
1 187
977
22%
1 104
1 053
4,8%
1 472
1 281
15%
2 166
2 085
3,9%

4 689
EPS
DKK
Released
Forecast
Spread
12,6
11,8
6,5%
19,2
16,2
19%
17,8
17,4
2,0%
23,7
20,8
14%
34,0
32,8
3,6%

72,2
Announcement Date02/17/201602/22/201702/21/201802/20/201902/19/2020

Quarterly publications
Previous periodNext period
Quarterly results2019 Q42020 Q12020 Q22020 S12020 Q32020 Q4 (e)
Sales
M DKK
Released
Forecast
Spread
2 961
2 755
7,5%
892
894
-0,21%
5 451
5 457
-0,11%
6 343
6 164
2,9%
1 724
1 475
17%

1 797
Operating income
(EBITDA)
M DKK
Released
Forecast
Spread
2 294
1 911
20%
78,0
64,1
22%
4 505
4 564
-1,3%
4 583
4 480
2,3%
868
549
58%

604
Operating profit
(EBIT)
M DKK
Released
Forecast
Spread
2 176
1 927
13%
71,0
60,5
17%
4 497
4 534
-0,82%
4 568
4 389
4,1%
858
451
90%

574
Pre-Tax Profit
(EBT)
M DKK
Released
Forecast
Spread
1 955
1 833
6,7%
354
67,5
425%
4 328
4 557
-5,0%
4 682
4 682
0,00%
671
470
43%

523
Net income
M DKK
Released
Forecast
Spread
1 472
1 401
5,0%
269
76,8
250%
3 378
3 638
-7,2%
3 647
4 573
-20%
530
380
39%

428
EPS
Released
Forecast
Spread
25,8
21,6
19%
4,09
1,19
244%
51,4
55,8
-8,0%
55,5
70,2
-21%
8,04
5,93
36%

6,58
Announcement Date02/19/202005/06/202008/12/202008/12/202011/04/2020

Financial data source
© 2020 S&P Global Market Intelligence
© 2020 Factset
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise